Matrix metalloproteinases: pathways of induction by bioactive molecules.
about
Influence of mast cells in drug-induced gingival overgrowthAntifibrotic therapies to control cardiac fibrosisUsing extracellular matrix proteomics to understand left ventricular remodelingRole of adiponectin receptors in endothelin-induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heartCardiac fibroblast: the renaissance cell.Sphingosine 1-Phosphate Receptors: Do They Have a Therapeutic Potential in Cardiac Fibrosis?Effects of early and late chronic pressure overload on extracellular matrix remodeling.Regulation of MMP2 and MMP9 metalloproteinases by FSH and growth factors in bovine granulosa cellsExercise training reduces fibrosis and matrix metalloproteinase dysregulation in the aging rat heart.The origin of fibroblasts and mechanism of cardiac fibrosisThe interferon-gamma-induced GTPase, mGBP-2, inhibits tumor necrosis factor alpha (TNF-alpha) induction of matrix metalloproteinase-9 (MMP-9) by inhibiting NF-kappaB and Rac protein.Matrix metalloproteinases and diabetic vascular complications.Natriuretic peptides: novel therapeutic targets in heart failure.Matrix metalloproteases: underutilized targets for drug deliveryDecreased Prolidase Activity in Patients with Posttraumatic Stress Disorder.Granulocyte colony-stimulating factor partially repairs the damage provoked by Trypanosoma cruzi in murine myocardium.Aging, exercise, and extracellular matrix in the heartCardiac fibroblast physiology and pathology.Gynura procumbens ethanolic extract suppresses osteosarcoma cell proliferation and metastasis in vitroSynergic and antagonistic relationship between MMP-2 and MMP-9 with fibrosis and inflammation in Chagas' cardiomyopathy.Management of cardiac fibrosis in diabetic rats; the role of peroxisome proliferator activated receptor gamma (PPAR-gamma) and calcium channel blockers (CCBs)Modifications of the radiosensitivity of a renal cancer cell line as a consequence of stable TIMP-1 overexpression.Anti-inflammatory activity of an ethanolic Caesalpinia sappan extract in human chondrocytes and macrophages.Serum prolidase activity, oxidative stress, and nitric oxide levels in patients with bladder cancer.A murine model of alcoholic cardiomyopathy: a role for zinc and metallothionein in fibrosis.Association between polymorphisms in the renin-angiotensin system genes and prevalence of spontaneously aborted fetuses.Effect of acute and chronic exercise on plasma matrix metalloproteinase and total antioxidant levels.Effects of long-term vardenafil treatment on the development of fibrotic plaques in a rat model of Peyronie's disease.The Prolidase Activity, Oxidative Stress, and Nitric Oxide Levels of Bladder Tissues with or Without Tumor in Patients with Bladder Cancer.Endothelin-1 in the human myocardium and circulating plasma: evaluation before, during and after correction of aortic stenosis with aortic valve replacement.An Injectable Oxygen Release System to Augment Cell Survival and Promote Cardiac Repair Following Myocardial Infarction.Beyond the matrix: MMP2 as critical regulator of inflammation-mediated vascular dysfunction.Preterm prelabor rupture of the membranes: A disease of the fetal membranes.Endoplasmic Reticulum Protein TXNDC5 Augments Myocardial Fibrosis by Facilitating Extracellular Matrix Protein Folding and Redox-Sensitive Cardiac Fibroblast Activation.Increased activities of cardiac matrix metalloproteinases matrix metalloproteinase (MMP)-2 and MMP-9 are associated with mortality during the acute phase of experimental Trypanosoma cruzi infection.
P2860
Q21285095-C7F10CFB-29D0-48D5-9206-649D2C3A80FAQ26745841-7489BCA1-C5CF-4C72-B5A3-DD86BD2C27A4Q26863127-5BB51DAB-A279-4337-807E-F6B78C87516AQ28568921-BA4D074D-D861-4089-AC34-C6C718A3CBBCQ30467800-41A2CBC3-F8F3-4C93-901F-61D67BACE846Q33753317-0D2A8B3A-7306-4DEB-ABF4-247D9DA0450AQ33823159-B7889AE0-6876-4FF9-80AB-9011D2AD2B70Q34562488-10E9343F-DD74-4B37-AFC9-A5A79C3FF0E5Q34592384-65B3251B-B7AE-4171-B72B-5E67C8B8D831Q34994036-8BC6B5D0-4338-4DFF-8D6D-4B109301EE84Q35011136-3071011A-E662-4F66-8A60-CC29F0417A76Q36081593-47B8A16D-327A-4798-BB70-48ECAC2A271DQ36317213-C53F67F8-4DB0-406F-9061-E89D6FD39A74Q36761849-F9B80508-3D69-490A-9104-6DFFC1D85AF7Q37136988-7F0DDAD5-76C2-4393-BCA1-A28776974C4BQ37230882-DF89DEF7-EF3D-4463-BD23-268BFAD77C37Q37332371-7626C4BB-9534-4AF7-8A30-812506525599Q38423895-D25C3695-6328-4473-AA12-3E4772FE4D61Q39110122-F97E7B2E-5F47-4026-94A8-9C05FF8F5AC8Q39329438-74D96C72-1333-47E2-8248-269188D88D3AQ39766035-13D41154-143B-46DE-8532-50AB0F1712FEQ40159615-1892031D-55D3-4916-996D-F2B8494F5E38Q41261105-A3CFA5DC-D090-458F-9D2A-7DA4032BA22DQ42548111-CC490F8D-B07A-46F1-94D4-C75E5C8703B5Q43239707-65C55826-F40D-48A8-ACDC-D147E5C56D7AQ43581806-EFF9545D-8128-4FB0-A9E9-7D0234F7F66AQ43628722-D4B3CE15-5651-4333-A3FB-4335E59029EBQ46936674-BCE4FD3B-A114-48F8-B6A6-B6C404610026Q47262524-A11010CF-73D8-4D96-AC46-F0E4C0EB77ECQ49096230-01810FD4-4E4B-4989-AC39-21BB9FCDF4C8Q49865710-7CFD4707-A1AF-4BAB-A0C2-4E5609023C33Q50080358-07B9F951-1E14-48A1-99CF-83744510B988Q51803137-30C01591-8538-47FB-9645-4B47516AF07DQ52657397-4AF35DEF-B0F0-464E-BD4A-B751E0C8C97EQ54534950-862428A7-3EB2-485A-BB27-53971B620587
P2860
Matrix metalloproteinases: pathways of induction by bioactive molecules.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Matrix metalloproteinases: pathways of induction by bioactive molecules.
@ast
Matrix metalloproteinases: pathways of induction by bioactive molecules.
@en
type
label
Matrix metalloproteinases: pathways of induction by bioactive molecules.
@ast
Matrix metalloproteinases: pathways of induction by bioactive molecules.
@en
prefLabel
Matrix metalloproteinases: pathways of induction by bioactive molecules.
@ast
Matrix metalloproteinases: pathways of induction by bioactive molecules.
@en
P2093
P1476
Matrix metalloproteinases: pathways of induction by bioactive molecules.
@en
P2093
John C Burnett
Lisa C Costello-Boerrigter
Toshihiro Tsuruda
P356
10.1023/B:HREV.0000011394.34355.BB
P577
2004-01-01T00:00:00Z
P6179
1035665964